Zn-BTC (H3BTC refers to 1, 3, 5-benzoic acid) MOF was used as a self-template and a zinc source to prepare ZnS/NiS₂ with a layered heterogeneous structure as a promising electrode material using cation exchange and solid-phase vulcanization processes. The synergistic effect of the two metal sulfides enhances the application of ZnS/NiS₂. And the high specific surface area and abundant active sites further promote the mass/charge transfer and redox reaction kinetics. In the three-electrode system, the specific capacitance was as high as 1547 F/g at a current density of 1 A/g, along with satisfactory rate capability (1214 F/g at 6 A/g) and cycling performance. Coupled with activated carbon (AC), the prepared hybrid device (ZnS/NiS₂ as the positive electrode and AC as the negative electrode) (ZnS/NiS₂/AC) can be operated under a potential window of 1.6 V and provides a high energy density of 26.3 Wh/kg at a power density of 794 W/kg. Notably, the assembled ZnS/NiS₂//AC showed little capacity degradation after 5000 charge/discharge cycles.

The spread of multidrug-resistant mycobacterium strains requires the development of new approaches to combat diseases caused by these pathogens. For that, photodynamic inactivation (PDI) is a promising approach. In this study, a tricarbocyanine (TCC) is used for the first time as a near-infrared (740 nm) activatable PDI photosensitizer to kill mycobacteria with deep light penetration. For better targeting, a novel tricarbocyanine dye functionalized with two trehalose units (TCC2Tre) is developed. The photodynamic effect of the conjugates against mycobacteria, including Mycobacterium tuberculosis, is evaluated. Under irradiation, TCC2Tre causes more effective killing of mycobacteria compared to the photosensitizer without trehalose conjugation, with 99.99% dead vegetative cells of M. tuberculosis and M. smegmatis. In addition, effective photoinactivation of dormant forms of M. smegmatis is observed after incubation with TCC2Tre. Mycobacteria treated with TCC2Tre are more sensitive to 740 nm light than the Gram-positive Micrococcus luteus and the Gram-negative Escherichia coli. For the first time, this study demonstrates the proof of principle of in vitro PDI of mycobacteria including the fast-growing M. smegmatis and the slow-growing M. tuberculosis using near-infrared activatable photosensitizers conjugated with trehalose. These findings are useful for the development of new efficient alternatives to antibiotic therapy.